Top compounds associated with response to WLS


Feature Type Standardized
Nominal ANOVA
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.044 0.6
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.025 0.6
mRNA ML050 CTRPv2 pan-cancer AAC -0.024 0.6
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.6
mRNA Dasatinib FIMM pan-cancer AAC 0.12 0.6
mRNA triptolide CTRPv2 pan-cancer AAC 0.022 0.6
mRNA linifanib CTRPv2 pan-cancer AAC -0.022 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.022 0.6
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.023 0.6
Download CSV